Delivery Order SPE2DB20D3103-SPE2DB25FP2F1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,677.03 firm-fixed-price delivery order is for the supply of 4565941363 Pyridium 200 mg tablets in 100-count packages. The contract has an ultimate completion date of September 26, 2024 and was awarded on September 25, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a significant...
- This federal contract award is for the delivery of Pyridium 200 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 28, 2025. The contract has a ceiling value of $1,168.07 and is a firm fixed-price delivery order contract with a completion date of March 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Phenazopyridine 200 mg tablets (100 count) under a firm fixed-price contract valued at $2,463.42, with an ultimate completion date of August 7, 2025. This non-set-aside award was issued on August 6, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,070.28 to AmerisourceBergen Drug Corp for the supply of Phenazopyridine Hydrochloride, a urinary analgesic pharmaceutical product. This firm fixed-price delivery order, issued on November 18, 2025, with an ultimate completion date of December 16, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was competitively made with no...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,662.56 to AmerisourceBergen Drug Corp for phenazopyridine hydrochloride on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $818.04 delivery order to Amerisourcebergen Drug Corporation for 200mg phenazopyridine tablets. Under the firm fixed price contract, Amerisourcebergen will deliver 100 count bottles of the medication to a location in Conshohocken, Pennsylvania by September 25, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was issued against an existing indefinite delivery/indefinite quantity contract vehicle....
- This $2,317.25 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of 4,565,327,024 units of the pharmaceutical product Phenazopyridine 100 mg tablets. There is no set-aside designation for this award. AmerisourceBergen, a major pharmaceutical distributor, holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of...
- The Defense Logistics Agency Troop Support Medical awarded a $752 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 200 mg phenazopyridine tablets. Under this firm fixed price contract, Amerisourcebergen will deliver 100 tablets of the specified medication to a location in Conshohocken, Pennsylvania by September 8, 2023 to fulfill requirements for the Defense Logistics Agency's medical supply program. No set aside designation or subcontractors were identified for this...
- This federal contract award, with ID SPE2DB22D3102|SPE2DB24FL0DA, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,330.71 firm fixed-price delivery order is for the supply of 4,563,744,487 units of the medication Phenazopyridine 100 mg tablets. The contract has an ultimate completion date of February 23, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $922 to Amerisourcebergen Drug Corporation for 100 tablets of 100 milligram phenazopyridine. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is September 25-26, 2023. As a top pharmaceutical supplier to the Department of Defense, Amerisourcebergen will deliver this generic medication to support DLA's medical readiness and logistics...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP2F1Delivery Order
The Defense Logistics Agency awarded a $1,222.86 delivery order to AmerisourceBergen Drug Corp for Pyridium 200 mg tablets (100-count units) on June 18, 2025, with a completion date of June 20, 2025. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military and federal healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company regularly fulfills competitive delivery orders through the DLA Medical Supply Chain for military healthcare programs and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. This award for Pyridium reflects the company's established capability to meet federal pharmaceutical procurement requirements through its existing master contract vehicle, enabling efficient fulfillment of medical supply needs for the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/18/25 |